FDCTech Restates 2024 & 2025 Financials, Discloses Material Weaknesses, Citing Non-Reliance on Prior Reports
Summary
FDCTech restated its 2024 and 2025 financials and issued a non-reliance notice on prior reports, citing material weaknesses in internal controls, despite reporting a return to profitability.
Key Events · Corporate Governance and Compliance · FDCT
-
Financial Restatement & Non-Reliance
FDCTech restated its 2024 and 2025 financial statements and issued a non-reliance notice on previously filed reports due to identified errors. This is the second amendment to the 2025 10-K, further correcting financials for multiple periods.
-
Material Weaknesses in Internal Controls
Management identified four material weaknesses, including inadequate segregation of duties, lack of written policies, limited U.S. GAAP expertise, and weak controls over related-party transactions, indicating significant ongoing control deficiencies.
-
Improved Financial Performance (Restated)
Despite the restatement, the company reported a significant financial turnaround for 2025, with revenues increasing 29.8% to $34.96 million and net income attributable to shareholders of $5.80 million, eliminating its accumulated deficit to an accumulated surplus of $3.40 million.
-
Auditor Change & Reaudit
The previous auditor was dismissed in April 2025 due to being a 'Prohibited Service Provider' by OTC Markets, leading to a reaudit of 2024 financials by the new independent registered public accounting firm, LAO Professionals.
Analysis · FDCT · Technology
FDCTech has filed a second amendment to its 2025 Annual Report, restating financial statements for both 2024 and 2025. This follows a non-reliance notice on previously issued financials due to identified errors, casting significant doubt on the reliability of past reporting. The company also disclosed four material weaknesses in internal controls, including inadequate segregation of duties and U.S. GAAP expertise, indicating systemic issues in financial oversight. While the restated financials show substantial revenue growth and a return to profitability, these positive developments are severely undermined by the fundamental issues with financial integrity and corporate governance. The ongoing legal challenges and the need for repeated restatements highlight a critical risk for investors.
At the time of this filing, FDCT was trading at $0.06 on OTC in the Technology sector, with a market capitalization of approximately $25.8M. The 52-week trading range was $0.00 to $0.12. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.